NCT02955368View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 28, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions

HypertensionHypercholesterolemia

Interventions

DRUG

DP-R212

DP-R212 + C1-R212 placebo + C2-R212 placebo

DRUG

C1-R212

DP-R212 placebo + C1-R212 + C2-R212 placebo

DRUG

C2-R212

DP-R212 placebo + C1-R212 placebo + C2-R212

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alvogen Korea

INDUSTRY